Immunodiagnostics Market Report by Product, Technology, Application, End User, and Region 2024-2032
세계 면역진단 시장 규모는 2023년 188억 달러에 달했습니다. 향후 IMARC Group은 2024-2032년까지 6.7%의 연평균 성장률(CAGR)을 보이며 2032년까지 343억 달러에 달할 것으로 예상하고 있습니다.
면역진단은 항원 항체 반응을 이용하여 감염 및 만성 질환을 검출하는 체외 진단 기술입니다. 방사선, 형광, 발색 효소, 프로브를 사용하여 질병의 진행을 확인하기 위한 표적 범위의 확대를 돕는 항체를 확인합니다. 면역 진단은 효소 결합 면역 흡착 측정법, 화학 발광법, 방사성 면역 분석법, 신속 검사를 위한 다양한 시약, 기기 및 소프트웨어 기반 솔루션도 사용합니다. 이러한 솔루션은 암, 자가면역질환, 호흡기질환, 내분비질환, 종양질환 등의 질병 진단, 법의학 심리학, 환경 및 식품 분석 등에 널리 활용되고 있습니다. 그 결과, 면역진단은 병원, 임상실험실, 연구기관, 학술기관 등 다양한 분야에 적용되고 있습니다.
면역진단 시장 동향 :
대중들 사이에서 만성 질환과 감염성 질환이 증가하고 있는 것은 시장 성장을 가속하는 주요 요인 중 하나입니다. 또한, 이러한 질병에 취약한 노인 인구 증가는 시장 성장을 가속하고 있습니다. 또한, B형 간염, 당뇨병, 암과 같은 질병에 대한 치료법에 대한 소비자의 인식이 높아지면서 면역 진단 키트, 분석기 및 분석 장비 수요에 긍정적인 영향을 미치고 있습니다. 또한, 차세대 면역진단 플랫폼 개발 등 다양한 기술 발전이 시장 성장을 가속할 것으로 예상됩니다. 이러한 첨단 현장진단(POCT) 시스템은 패혈증, 급성 심근경색 및 사망률이 높은 기타 의료 질환에 대한 진단 역량을 강화할 것입니다. 또한, 신흥국을 중심으로 의료 인프라가 개선되고 있으며, 개인 맞춤형 의약품에 대한 대중의 요구가 증가하고 있는 점도 시장 성장을 가속할 것으로 예상됩니다.
본 보고서에서 다룬 주요 질문들
- 면역진단 시장 세계 시장 규모는?
- 2024-2032년 세계 면역진단 시장의 예상 성장률은?
- 세계 면역진단 시장을 이끄는 주요 요인은?
- 코로나19가 세계 면역진단 시장에 미치는 영향은?
- 세계 면역진단 시장의 용도별 시장 현황은?
- 세계 면역진단 시장의 최종사용자별 시장 현황은?
- 세계 면역진단 시장의 주요 지역은?
- 세계 면역진단 시장의 주요 진출 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 면역진단 시장
- 시장 개요
- 시장 분석
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 제품별
제7장 시장 분석 : 기술별
- 효소 면역측정법
- 화학 발광 면역측정법
- 형광 면역측정
- 방사 면역측정
- 신속 시험
- 기타
제8장 시장 분석 : 용도별
- 감염증
- 종양학 및 내분비학
- 간염 및 레트로바이러스
- 뼈 및 미네랄
- 자가면역
- 심장 바이오마커
- 기타
제9장 시장 분석 : 최종사용자별
- 병원
- 임상시험실
- 학술 연구센터
- 제약 및 바이오테크놀러지 산업
- 기타
제10장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter의 Five Forces 분석
- 개요
- 바이어의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 진출업체의 위협
- 대체품의 위협
제14장 가격 분석
제15장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 개요
- Abbott Laboratories
- Arkray Inc.
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A.
- F. Hoffmann-La Roche AG
- Immunodiagnostic Systems Holdings PLC
- Johnson & Johnson
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
LSH
The global immunodiagnostics market size reached US$ 18.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 34.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
Immunodiagnostics refers to an in-vitro diagnostic technology that uses antigen-antibody reaction for the detection of infectious and chronic diseases. It involves the use of radiological, fluorescent or color-forming enzymes and probes for the identification of antibodies that aid in enhancing the targeting range to identify disease progression. Immunodiagnostics also uses various reagents, instruments and software-based solutions for enzyme-linked immunosorbent assay, chemiluminescence, radioimmunoassay and rapid testing. These solutions are widely used for diagnosing diseases, such as cancer and autoimmune, respiratory, endocrine and oncological disorders, along with forensic psychology and environmental and food analysis. As a result, immunodiagnostics finds extensive applications across hospitals, clinical laboratories and research and academic institutes.
Immunodiagnostics Market Trends:
The increasing prevalence of chronic medical ailments and infections among the masses is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. There is also an escalating awareness among the consumers regarding the available treatment alternatives for ailments, such as hepatitis B, diabetes and cancer, which is positively impacting the demand for immunodiagnostics kits, assays and analyzers. Additionally, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market toward growth. These advanced point-of-care testing (POCT) systems offer enhanced diagnostic facilities for sepsis, acute cardiac infractions and other medical disorders with higher mortality rates. Other factors, including the increasing requirement for personalized medicines among the masses, along with extensive improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global immunodiagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, technology, application and end user.
Breakup by Product:
Reagents
Instruments
Software and Services
Breakup by Technology:
Enzyme-Linked Immunosorbent Assay
Chemiluminescence Immunoassay
Fluorescent Immunoassay
Radioimmunoassay
Rapid Test
Others
Breakup by Application:
Infectious Diseases
Oncology and Endocrinology
Hepatitis and Retrovirus
Bone and Mineral
Autoimmunity
Cardiac Biomarker
Others
Breakup by End User:
Hospitals
Clinical Laboratories
Academic and Research Centers
Pharmaceutical and Biotechnology Industry
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arkray Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Immunodiagnostic Systems Holdings PLC, Johnson & Johnson, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- 1. How big is the global immunodiagnostics market?
- 2. What is the expected growth rate of the global immunodiagnostics market during 2024-2032?
- 3. What are the key factors driving the global immunodiagnostics market?
- 4. What has been the impact of COVID-19 on the global immunodiagnostics market?
- 5. What is the breakup of the global immunodiagnostics market based on the application?
- 6. What is the breakup of the global immunodiagnostics market based on the end user?
- 7. What are the key regions in the global immunodiagnostics market?
- 8. Who are the key players/companies in the global immunodiagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Immunodiagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Enzyme-Linked Immunosorbent Assay
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Chemiluminescence Immunoassay
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Fluorescent Immunoassay
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Radioimmunoassay
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Rapid Test
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Application
- 8.1 Infectious Diseases
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Oncology and Endocrinology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Hepatitis and Retrovirus
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Bone and Mineral
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Autoimmunity
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Cardiac Biomarker
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Clinical Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Academic and Research Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Pharmaceutical and Biotechnology Industry
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Arkray Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 bioMerieux SA
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Bio-Rad Laboratories Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 DiaSorin S.p.A.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 F. Hoffmann-La Roche AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.7 Immunodiagnostic Systems Holdings PLC
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 Johnson & Johnson
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Siemens AG
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Sysmex Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Thermo Fisher Scientific Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
